SiNtx Technologies Inc (SINT)

[XFundManager]

Sintx Technologies PT Lowered to 0.07 cents.

Sintx Technologies (NASDAQ:SINT – ) had its price target dropped by equities researchers at Trident Capital Markets to 0.07 cents in a research note issued on Monday August 29th 2022 Stock Target Advisor reports. Trident Capital Markets’ price target would suggest a potential downside side of 86% from the stock’s current price.

Sintx Technologies, Inc., an advanced materials company, that has never turned a profit, and engages in the research, development, and commercialization of medical devices manufactured with silicon nitride ( non patent protected ) for biomedical, industrial, and anti-pathogenic applications primarily in the United States.

The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. The company has low cash reserves and the stock is pending delisting from Nasdaq to otc.